Literature DB >> 32202346

Iron deficiency-induced loss of skeletal muscle mitochondrial proteins and respiratory capacity; the role of mitophagy and secretion of mitochondria-containing vesicles.

Pieter A Leermakers1, Alexander H V Remels2, Marijke I Zonneveld3, Kasper M A Rouschop3, Annemie M W J Schols1, Harry R Gosker1.   

Abstract

Iron homeostasis is essential for mitochondrial function, and iron deficiency has been associated with skeletal muscle weakness and decreased exercise capacity in patients with different chronic disorders. We hypothesized that iron deficiency-induced loss of skeletal muscle mitochondria is caused by increased mitochondrial clearance. To study this, C2C12 myotubes were subjected to the iron chelator deferiprone. Mitochondrial parameters and key constituents of mitophagy pathways were studied in presence or absence of pharmacological autophagy inhibition or knockdown of mitophagy-related proteins. Furthermore, it was explored if mitochondria were present in extracellular vesicles (EV). Iron chelation resulted in an increase in BCL2/Adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and BNIP3-like gene and protein levels, and the appearance of mitochondria encapsulated by lysosome-like vesicular structures in myotubes. Moreover, mitochondria were secreted via EV. These changes were associated with cellular mitochondrial impairments. These impairments were unaltered by autophagy inhibition, knockdown of mitophagy-related proteins BNIP3 and BNIP3L, or knockdown of their upstream regulator hypoxia-inducible factor 1 alpha. In conclusion, mitophagy is not essential for development of iron deficiency-induced reductions in mitochondrial proteins or respiratory capacity. The secretion of mitochondria-containing EV could present an additional pathway via which mitochondria can be cleared from iron chelation-exposed myotubes.
© 2020 The Authors. The FASEB Journal published by Wiley Periodicals, Inc. on behalf of Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  extracellular vesicles; iron depletion; mitochondrial clearance; myotubes

Year:  2020        PMID: 32202346     DOI: 10.1096/fj.201901815R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

Review 1.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

2.  The Impact of Iron Dyshomeostasis and Anaemia on Long-Term Pulmonary Recovery and Persisting Symptom Burden after COVID-19: A Prospective Observational Cohort Study.

Authors:  Thomas Sonnweber; Philipp Grubwieser; Sabina Sahanic; Anna Katharina Böhm; Alex Pizzini; Anna Luger; Christoph Schwabl; Sabine Koppelstätter; Katharina Kurz; Bernhard Puchner; Barbara Sperner-Unterweger; Katharina Hüfner; Ewald Wöll; Manfred Nairz; Gerlig Widmann; Ivan Tancevski; Judith Löffler-Ragg; Günter Weiss
Journal:  Metabolites       Date:  2022-06-14

Review 3.  The Roles and Pathogenesis Mechanisms of a Number of Micronutrients in the Prevention and/or Treatment of Chronic Hepatitis, COVID-19 and Type-2 Diabetes Mellitus.

Authors:  Khalid M Sumaily
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

4.  Iron Deficiency and Recovery in Yeast: A Quantitative Proteomics Approach.

Authors:  Jose Navarrete-Perea; Angel Guerra-Moreno; Jonathan Van Vranken; Marta Isasa; Joao A Paulo; Steven P Gygi
Journal:  J Proteome Res       Date:  2021-04-02       Impact factor: 4.466

Review 5.  The effect of extracellular vesicles on the regulation of mitochondria under hypoxia.

Authors:  Yaodan Zhang; Jin Tan; Yuyang Miao; Qiang Zhang
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

6.  Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.

Authors:  Marta Medina-Carbonero; Arabela Sanz-Alcázar; Elena Britti; Fabien Delaspre; Elisa Cabiscol; Joaquim Ros; Jordi Tamarit
Journal:  Cell Mol Life Sci       Date:  2022-01-17       Impact factor: 9.261

7.  Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia.

Authors:  Elisabeth Wyart; Myriam Y Hsu; Alessio Menga; Paolo E Porporato; Roberta Sartori; Erica Mina; Valentina Rausch; Elisa S Pierobon; Mariarosa Mezzanotte; Camilla Pezzini; Laure B Bindels; Andrea Lauria; Fabio Penna; Emilio Hirsch; Miriam Martini; Massimiliano Mazzone; Antonella Roetto; Simonetta Geninatti Crich; Hans Prenen; Marco Sandri
Journal:  EMBO Rep       Date:  2022-02-24       Impact factor: 8.807

8.  Decreased haemoglobin levels are associated with lower muscle mass and strength in kidney transplant recipients.

Authors:  Joanna Sophia J Vinke; Hanneke J C M Wouters; Suzanne P Stam; Rianne M Douwes; Adrian Post; Antonio W Gomes-Neto; Melanie M van der Klauw; Stefan P Berger; Stephan J L Bakker; Martin H De Borst; Michele F Eisenga
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-06-03       Impact factor: 12.063

9.  BACH1 Expression Is Promoted by Tank Binding Kinase 1 (TBK1) in Pancreatic Cancer Cells to Increase Iron and Reduce the Expression of E-Cadherin.

Authors:  Liang Liu; Mitsuyo Matsumoto; Miki Matsui-Watanabe; Kyoko Ochiai; Bert K K Callens; Long Chi Nguyen; Yushi Kozuki; Miho Tanaka; Hironari Nishizawa; Kazuhiko Igarashi
Journal:  Antioxidants (Basel)       Date:  2022-07-27

10.  Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis.

Authors:  Hongrong Ding; Shujie Chen; Xiaohan Pan; Xiaoshuang Dai; Guihua Pan; Ze Li; Xudong Mai; Ye Tian; Susu Zhang; Bingdong Liu; Guangchao Cao; Zhicheng Yao; Xiangping Yao; Liang Gao; Li Yang; Xiaoyan Chen; Jia Sun; Hong Chen; Mulan Han; Yulong Yin; Guohuan Xu; Huijun Li; Weidong Wu; Zheng Chen; Jingchao Lin; Liping Xiang; Jun Hu; Yan Lu; Xiao Zhu; Liwei Xie
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-05-06       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.